
Romanos Sklavenitis-Pistofidis: Establishing targeted therapy for Multiple Myeloma with 1q+
Romanos Sklavenitis-Pistofidis, Instructor at Dana-Farber Cancer Institute, shared a post on X about a paper he coauthored with colleagues published in Blood Journal:
“Our paper on establishing targeted therapy for MM with 1q+ is online ahead of print in Blood Journal with Liz Lightbody, Mairead Reidy, Irene Ghobrial, Gaddy Getz and Salomon Manier!
We used a variety of approaches, including dependency screens, drug screens, scRNA-seq of patient tumors with subclonal 1q+, and single-cell cloning of a MM cell line! Tweetorial to follow upon publication!”
Authors: Romanos Sklavenitis-Pistofidis, Elizabeth Lightbody, Mairead Reidy, Junko Tsuji, Jean-Baptiste Alberge, Michelle Aranha, Matthew Davids, Maria Papaioannou, Gad Getz, Irene Ghobrial, Salomon Manier et al.
More posts featuring Romanos Sklavenitis-Pistofidis.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023